Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Charcot-Marie-Tooth Disease: An Overview of Genotypes, Phenotypes, and Clinical Management Strategies.
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Longitudinal change detection: Inference on the diffusion tensor along white matter pathways.
ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis.
Thalamic Atrophy is Associated with Development of Clinically Definite Multiple Sclerosis.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population.
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
[Cognitive Impairment in Multiple Sclerosis].
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Neurosarcoidosis.
Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.
Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome.
Corrigendum.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.

Pages